HBV-related antibodies in enrolled patients
| Group | HBcAb-negative, number (%) | HBcAb-positive, number (%) | Total |
|---|---|---|---|
| HBsAb-negative number (%) | |||
| RA | 0 | 177 | 177 |
| Other RDs | 0 | 13 | 13 |
| Total* | 0 | 190 (18.2) | 190 (18.2) |
| HBsAb-positive number (%) | |||
| RA | 109 | 673 | 782 |
| Other RDs | 18 | 52 | 70 |
| Total* | 127 (12.2) | 725 (69.6) | 852 (81.8) |
| Total | 127 (12.2) | 915 (87.8) | 1042 |
In the table, ‘Total*’ indicates the total number of patients in the upper two columns, RA and other RDs.
HBcAb, hepatitis B virus core antibody; HBsAb, hepatitis B virus surface antibody; HBV, hepatitis B virus; RA, rheumatoid arthritis; RD, rheumatic disease.